Carson Leslie Foundation Joins Forces with Children's Brain Tumor Network for Enhanced Pediatric Care

Carson Leslie Foundation and Children's Brain Tumor Network Collaborate

The Children's Brain Tumor Network (CBTN) recently announced the inclusion of the Carson Leslie Foundation in its Executive Council. This collaboration marks an important step in enhancing research and advocacy efforts aimed at improving outcomes for children diagnosed with various brain tumors.

Over the past four years, the Carson Leslie Foundation has made substantial contributions to CBTN projects, including a recent donation of $100,000 specifically for the medulloblastoma liquid biopsy project. This innovative approach seeks to offer a less invasive method for monitoring treatment progress in what is often a very aggressive form of pediatric brain cancer.

Jena Lilly, the Executive Director of CBTN, expressed enthusiasm about the collaboration: "We are thrilled to welcome the Carson Leslie Foundation to our Executive Council. Their expertise in research and advocacy will be invaluable as we work to improve the long-term prospects of children diagnosed with brain tumors."

The Carson Leslie Foundation holds a deep-seated commitment to advancing research that can lead to innovative treatments and ultimately a cure for brain tumors, especially medulloblastoma. Founded in memory of Carson Leslie, who tragically lost his life to this disease in 2010, the foundation is driven by a mission to ensure no child faces a brain cancer diagnosis without access to the best possible care and pioneering research. Ripley Martin, a Board Member of the foundation, highlighted the importance of unity among pediatric brain tumor organizations:

"The Carson Leslie Foundation's participation in the Executive Council is rooted in our belief that collaboration is crucial for progress in our fields of focus. We believe that by working together, we can make a real impact on the lives of affected children."

The Role of CBTN

The Children's Brain Tumor Network is a collaborative research initiative aimed at ensuring that no child suffers or succumbs to brain tumors. The consortium consists of 35 international member institutions that have collectively enrolled over 7,000 study participants and compiled more than 70,000 biospecimen samples. This initiative has resulted in the establishment of the most extensive repository of childhood brain tumors. Through a suite of cloud-based informatics and analytics platforms, CBTN facilitates real-time collaboration among researchers and clinicians focused on advancing pediatric brain cancer treatment.

To learn more about the impactful work being done by both the Carson Leslie Foundation and CBTN, visit their websites and discover how their partnership is contributing to the fight against pediatric brain cancers. Together, they present a united front, championing advancements that can transform care for children diagnosed with brain tumors and enhancing their chances for a brighter future.